AMRX

AMNEAL PHARMACEUTICALS INC

AMRX·03168L105·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist

AMRX (AMNEAL PHARMACEUTICALS INC) is held by 143 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($459.8M), VANGUARD PORTFOLIO MANAGEMENT LLC ($210.1M), VANGUARD CAPITAL MANAGEMENT LLC ($133.5M). Net institutional sentiment: Mixed.

143
Holders
(13 Elite)
$2.1B
Total Value
59% (157)
Consensus
93 buying - 64 selling
13F: Insider & Congress: Updated regularly
AMRX

Smart Money Verdict

View all
Loading verdict
Held by 143 funds
13 elite

Who's Trading

Source dates: Price Sep 22, 2026 · Insiders Sep 21, 2026 · Activists Aug 12, 2026 · Congress none

InsiderBKBUCHI J KEVINGift 20K shSep 17, 2026
InsiderBKBUCHI J KEVINExercise 20K shSep 11, 2026
InsiderBSBOYER ANDREW SGift 80K shSep 1, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
26.6M(+8.3%)$459.8M0.0%+53.32%
34
Increased
12.1M(+7.2%)$210.1M0.0%+22.63%
33
Increased
7.7M(+1.6%)$133.5M0.0%+24.49%
31
Increased
7.4M(+8.3%)$127.3M0.0%+68.39%
33
Increased
5.8M(+1.8%)$100.3M0.0%+185.56%
30
Increased
5.1M(+13.1%)$89M0.0%+95.63%
34
Decreased
4.1M(-11.4%)$71.1M0.0%+77.15%
0
Increased
3.9M(+5.6%)$67.3M0.0%+102.75%
31
Increased
3.5M(+9.8%)$60.6M0.0%+50.88%
32
Increased
3.3M(+2.5%)$57.6M0.0%+89.39%
30
Increased
3.3M(+29.3%)$55.9M0.1%+29.28%
37
Increased
3M(+5.2%)$52.2M0.0%+79.03%
31
Decreased
2.4M(-20.3%)$42.3M0.1%+57.45%
0
Decreased
2.1M(-1.7%)$37.2M0.0%+92.75%
0
Increased
1.9M(+12.2%)$33.1M0.0%+57.46%
32
Decreased
1.6M(-15.2%)$27.4M0.0%+70.35%
0
Increased
1.2M(+1.3%)$20.2M0.0%+24.61%
29
Increased
1.1M(+93.7%)$19.4M0.0%+42.86%
45
Increased
1M(+11.1%)$17.6M0.0%+77.01%
31
Increased
991,817(+2.0%)$17.2M0.0%+32.84%
29

Showing 1-20 of 165

1 / 9
AMRXAMRXAMNEAL PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used